CD8A and neoplasm: Administration of a vaccine formulation containing these peptide nanoparticles and a CpG adjuvant to tumor-bearing mice could efficiently stimulate antigen-specific CD8 + T cells, which in turn reduced the tumor growth and improved the survival in a C57BL/6 mice [23].